rituximab
roche,biogen
['ritux', ' uc ', 'imab ']
 rituximab (anti-cd20) failed to show improvement in uc patients b. siegmund q: are we depleting b cells at the right time window? maybe b cell depletion works in some uc patients. in our lab, we propose to treat uc1 (rather than uc2) patients during mucosal healing #uegweek22 
Mucosal Immunologist interested in the complexity of IBD. Associate Professor @Karolinskainst, Wallenberg Fellow & editor @MucosalImmunol. Opinions are my own